Heartflow

Heartflow Stock-Based Compensation

The Stock-Based Compensation (SBC) of Heartflow (HTFL) as of Nov 11, 2026 is 13.97 M USD. In the previous year, Stock-Based Compensation (SBC) was 10.21 M USD — a change of 36.74% (higher).

Stock-Based Compensation

13.97 MUSD

YoY

36.74%

Last updated:

Stock-Based Compensation (SBC) of Heartflow is 2025 13.97 M USD. Stock-Based Compensation (SBC) of Heartflow was 2024 10.21 M USD. It decreases by 36.74% higher compared to the previous year.

The Heartflow Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2023
11.87 M USD
Jan 1, 2024
10.21 M USD
Jan 1, 2025
13.97 M USD
The Heartflow Stock-Based Compensation history
YEARStock-Based CompensationYoY
13.97 MUSD+36.74%
10.21 MUSD-13.99%
11.87 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Heartflow Stock analysis

What does Heartflow do? Heartflow Inc generates revenue through its HeartFlow Platform, which includes AI-driven software solutions for diagnosing coronary artery disease. The company's products, such as HeartFlow FFRCT Analysis and Plaque Analysis, assist physicians in managing patient care by providing personalized 3D heart models derived from CCTA scans. These tools are sold to healthcare providers and hospitals, enabling non-invasive diagnosis and treatment planning for coronary artery disease. The RoadMap Analysis offers intuitive visualization of coronary arteries, helping physicians focus on critical areas during patient reviews. The HeartFlow Platform leverages artificial intelligence and computational fluid dynamics to create detailed cardiac models, positioning Heartflow Inc as a leader in medical technology for cardiovascular diagnostics. Its commercial-stage operations focus on delivering precision care solutions that improve diagnostic accuracy and patient outcomes. Healthcare institutions purchase these AI-powered tools to enhance their diagnostic capabilities without invasive procedures. Heartflow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Heartflow stock

Stock-Based Compensation (SBC) of Heartflow is 13.97 M USD in 2025.

Stock-Based Compensation (SBC) of Heartflow changed from 10.21 M USD to 13.97 M USD, representing a 36.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Heartflow since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Heartflow historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Heartflow

All Key Metrics — Heartflow